AI-generated virtual psychedelics bridge digital and therapeutic frontiers in mental health research
Giuseppe Riva, Giulia Brizzi, Clara Rastelli, Antonino Greco
Nature Mental Health February 1, 2026 DOI: 10.1038/s44220-025-00576-3 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Comment Peer reviewed |
|---|---|
| Citations | 1 |
| Key points | Artificial intelligence and virtual reality could simulate psychedelic experiences for use in therapy, addressing regulatory, methodological, and safety challenges. |
Abstract
Psychedelic-assisted therapy shows promise for mental health treatment but faces regulatory, methodological and safety challenges. In this Comment, we propose using artificial intelligence and virtual reality to simulate similar experiences to those produced by traditional psychedelic compounds for use in psychedelic-assisted therapy modalities.
Citations in the library
Cites 9
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- Global Street Food: la cocina de la calle Diseño interior 2009
- Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Translational Psychiatry November 8, 2021
- Psychedelics and virtual reality: parallels and applications. Therapeutic Advances in Psychopharmacology August 14, 2020
and 4 more in the library